Business Combination, Contingent Consideration, Product Related, Milestone Payable, Amount

No definition available.

Name:	aytu_BusinessCombinationContingentConsiderationProductRelatedMilestonePayableAmount
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Business Combination, Contingent Consideration, Product Related, Milestone Payable, Discount Rate

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentConsiderationProductRelatedMilestonePayableDiscountRate
Namespace Prefix:	aytu_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479907/805-20-50-5

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479581/805-30-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479668/805-30-25-6

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 35
-Paragraph 1
-Subparagraph (b)
-SubTopic 30
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479613/805-30-35-1

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Other Liabilities - Contingent Consideration - Business Combination (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jun. 30, 2022	Feb. 29, 2020
Business Acquisition [Line Items]
Contingent consideration	$ 0.0	$ 0.4
Innovus Pharmaceuticals, Inc
Business Acquisition [Line Items]
Business combination, contingent consideration, product related, milestone payable, amount			$ 0.2
Business combination, contingent consideration, product related, milestone payable, discount rate (as a percent)			30.00%